Call for Proposals
Currently, the majority of the chemicals, polymers, and active pharmaceutical
ingredients (APIs) are manufactured by the chemical and pharma industry using
fossil fuels and petrochemicals as feedstock. Existing production processes are
Green House Gas (GHG) emission intensive. With increasing population the demand for fossil-fuel based chemicals, polymers and APIs is projected to grow exponentially, leading to further rise in GHG emissions. To significantly reduce
carbon emission, India needs to change the ways in which chemicals, polymers and
APIs are being produced in the country. With advancement in biotechnology,
particularly in synthetic biology and metabolic engineering, India is poised to
decarbonise the chemical and pharma industry by transitioning to less carbon-2
intensive biomanufacturing of chemicals, polymers, and APIs using sustainable biobased feedstocks.